FACULTY


MELANOMA BRIDGE 2016
November 30th - December 3rd 2016



Sanjiv Agarwala
St. Luke's University Hospital and Temple University, Bethlehem, Pennsylvania

Paolo A. Ascierto
Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, National Cancer Institute "Fondazione G. Pascale" of Naples, Italy

Davide Bedognetti
Sidra Medical and Research Center, Doha, Qatar

Carlo Bifulco
Earle A. Chiles Research Institute, Robert W. Franz Cancer Research Center, Providence Portland Medical Center, Portland, Oregon

Gerardo Botti
National Cancer Institute "Fondazione G. Pascale" of Naples, Italy

Luigi Buonaguro
National Cancer Institute "Fondazione G. Pascale" of Naples, Italy

Gennaro Ciliberto
National Cancer Institute "Fondazione G. Pascale" of Naples, Italy

Sandra Demaria
Weill Cornell medical College, New York, NY

Reinhard Dummer
University of Zurich Hospital, Department of Dermatology, Zurich

Connie Duong
INSERM (National Institute of Health and Medical Research), Institut Gustave Roussy, Villejuif, France

Alexander Eggermont
Institut de Cancérologie Gustave Roussy, Villejuif, Paris-Sud, France

Soldano Ferrone
Massachusetts General Hospital, Boston, Massachusetts

Silvia C. Formenti
Department of Radiation Oncology, Weill Cornell Medical College, New York

Jerome Galon
INSERM (National Institute of Health and Medical Research), Paris, France

Claus Garbe
Division of Dermatologic Oncology Department of Dermatology Eberhard Karls University Tuebingen, Germany

Ruth Halaban
Department of Dermatology, Yale University School of Medicine, New Haven

Samir Khleif
Georgia Cancer Center, Augusta University, Augusta, Georgia

Celeste Lebbe
Dermatology, APHP Hopital Saint Louis, Paris France

Karl Lewis
Division of Medical Oncology, University of Colorado, Denver, CO, USA

Roger Lo
Melanoma Clinic in Dermatology Member, Jonsson Comprehensive Cancer Center David Geffen School of Medicine at UCLA, Los Angeles, California

Jason Luke
Department of Hematology/Oncology, University of Chicago Comprehensive Cancer Center Chicago, IL, USA

Alessandro Lugli
Institute of Pathology, University of Bern, Switzerland

Francesco M. Marincola
Sidra Medical and Research Center, Doha, Qatar

Giuseppe Masucci
Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden

Lluis Mir
CNRS, Université Paris-Sud and Institut de Cancérologie Gustave Roussy, Villejuif, France

Nicola Mozzillo
Department Melanoma and Soft Tissues, National Cancer Institute "Fondazione G. Pascale" of Naples, Italy

Willem W. Overwijk
Department of Melanoma Medical Oncology - Research, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas

Franck Pages
Service d'Immunologie Biologique, Hôpital Européen Georges Pompidou, Paris, France

Giuseppe Palmieri
Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy

Michael Postow
Memorial Sloan Kettering Cancer Center, New York

Igor Puzanov
Melanoma Section Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY

Paul Sondel
University of Wisconsin School of Medicine and Public Health, Milwaukee

David Frank Stroncek
Department of Transfusion Medicine, NIH Clinical Center, Bethesda, Maryland

Janis M. Taube
Johns Hopkins University SOM, Baltimore, Maryland

Alessandro Testori
Dermato-oncology Surgery Division, European Institute of Oncology, Milan, Italy

Per thor Straten
Department of Immunology and Microbiology, University of Copenhagen, Denmark

Magdalena Thurin
Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, NCI, NIH, Rockville, Maryland

Ena Wang
Sidra Medical and Research Centre, Doha, Qatar

Jennifer A. Wargo
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas

Hassane Zarour
University of Pittsburgh Cancer Institute Hillman Cancer Center, Pennsylvania

Laurence Zitvogel
Institut Gustave Roussy, Villejuif, Paris-Sud, France




For information please contact info@melanomabridge.org